Trends in Hospital Inpatient Drug Costs: Issues and Challenges

October 11, 2016

AHA also released an infographic outlining how rising drug prices are hurting hospitals and potentially limiting access to care for patients.

Key Resources

Related Resources

Letter/Comment
AHA Urges HHS and HRSA to Provide Flexibility Administering 340B Program During COVID-19
Public
Dear Secretary Azar: On behalf of our nearly 2,000 340B member hospitals, the American Hospital Association (AHA) urges the Department of Health and Human…
Letter/Comment
AHA Comments on CMS 340B Hospital Survey Notice
Letter/Comment
AHA Comments on Drug Pricing Bill Under Consideration in the House
Public
The AHA today submitted comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare…
Special Bulletin
House Democrats Release Legislation Aimed at Addressing High Drug Prices
Member
House Democratic leaders today released the Lower Drug Costs Now Act, a bill that would make a series of changes to the Medicare program in an effort to lower…
Letter/Comment
AHA, Other Associations to Senate Finance Committee on Markup of Drug Pricing Bill
Public
The AHA, AAMC and FAH agree with the Committee’s goal of reducing the price of drugs, and applaud many of the steps outlined in the description of the…
Special Bulletin
Special Bulletin: White House Releases Executive Order on Improving Price and Quality Transparency
Member
The White House June 24 released an executive order on “improving price and quality transparency in American health care.” The executive order focuses on five…